Randomized trial of daily high-dose vitamin D-3 in patients with RRMS receiving subcutaneous interferon beta-1a

Raymond Hupperts*, Joost Smolders, Reinhold Vieth, Trygve Holmoy, Kurt Marhardt, Myriam Schluep, Joep Killestein, Frederik Barkhof, Manolo Beelke, Luigi M. E. Grimaldi, SOLAR Study Grp

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)E1906-E1916
Number of pages11
JournalNeurology
Volume93
Issue number20
DOIs
Publication statusPublished - 12 Nov 2019

Keywords

  • MULTIPLE-SCLEROSIS ACTIVITY
  • DOUBLE-BLIND
  • 25-HYDROXYVITAMIN D
  • SUPPLEMENTATION
  • MULTICENTER
  • CALCIUM
  • SAFETY
  • RISK
  • CHOLECALCIFEROL
  • PROGRESSION

Cite this